Showing 691-700 of 1318 results for "".
DermWireTV: Spevigo for GPP; Derms on Acne Experience; IFPA Takes PsO to the Gaming World; La Roche-Posay at the US Open
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-spevigo-for-gpp-derms-on-acne-experience-ifpa-takes-pso-to-the-gaming-world-la-roche-posay-at-the-us-open/20136/Boehringer Ingelheim’s Spevigo is the first FDA-approved treatment option for generalized pustular psoriasis (GPP) flares in adults. Spesolimab is a novel, selective antibody that blocks the activation of the interleukin-36 receptor. Dermatologists, dermatology physician assistants, and dermatologyIncrease Engagement on Your Practice Facebook Page
https://practicaldermatology.com/topics/practice-management/facebook-engagement/18235/There are standard, contemporary and emerging ways to add more excitement to your Facebook network. As a digital marketer, you should identify and adopt the best practices. This includes generating & sharing unique content that your dermatology website generates and collaborating with blog ownerDerm Surgeries Top 10M; VCS Kicks Off; Tildrakizumab with FDA
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-derm-surgeries-top-10m-vcs-kicks-off-tildrakizumab-with-fda/18468/Dermatologic surgical procedures continue to increase in popularity. Dermatologic surgeons performed nearly 10.5 million medically necessary and cosmetic procedures in 2016—up five percent from 2015 and up 31 percent since 2012. Results are presented in the 2016 American Society for Dermatologic SurRhatigan to Merz, MOC Dissatisfaction, Syneron-Candela Sale
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-rhatigan-to-merz-moc-dissatisfaction-syneron-candela-sale/18485/Industry veteran Bob Rhatigan is the new President and Chief Executive Officer of Merz North America. Patrick Urban is new Chief Commercial Officer. In a transaction valued at approximately $397 million, an affiliate of funds advised by Apax Partners will acquire all of the outstanding shares of SySuperficial Radiation for Keloids: SRT-100 in Practice
https://practicaldermatology.com/topics/skin-cancer-photoprotection/superficial-radiation-for-keloids-srt-100-in-practice/19040/Keloids are common. Certain patients, especially patients of color, are more prone to the development of keloids in certain locations, especially areas such as the chest, back, and other areas. Most studies that show that keloids can occur in up to 90 percent of cases when they're excised. The use oPearls for Monitoring and Managing Itch: An Expert Panel
https://practicaldermatology.com/topics/atopic-dermatitis/pearls-for-monitoring-and-managing-itch-an-expert-panel/26999/Pearls for Monitoring and Managing Itch: An Expert PanelScientifically Speaking: The Truth About Skincare
https://practicaldermatology.com/series/scientifically-speaking/scientifically-speaking-the-truth-about-skincare/19876/From workhorse ingredients like antioxidants and retinol to newer molecules that address pigmentation and aging, there is a lot of noise in the skincare marketplace. And that's without talking about "natural" formulations. Joel L. Cohen, MD gets to the heart of the science, in a conversation with DeBehind the Pulse: Considerations for evaluating a picosecond laser
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/behind-the-pulse-considerations-for-evaluating-a-picosecond-laser/19749/If you are considering a picosecond system, this is the one webinar you will want to see. With content developed by Candela’s VP of Technology Research and Distinguished Fellow, Xiaoming Shang, PhD, along with a presentation by Perry Tomasetti, Candela’s Senior Director, Product Development, you wilAllergan Commemorates 25th Anniversary of the First Two Approved Uses of BOTOX® (onabotulinumtoxinA)
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/allergan-commemorates-25th-anniversary-of-the-first-two-approved-uses-of-botox-onabotulinumtoxina-/19136/Allergan, Inc. (NYSE: AGN) today announced the launch of a video recognizing the physician pioneers and patient communities who contributed to the development of BOTOX® (onabotulinumtoxinA), one of the most recognized pharmaceutical brands in the United States. The video kicks off a year-long campaiBlunt Tip Microcannulas- No Bruise Fillers
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/dermasculpt-injectable-fillers-no-bruise-fillers/19280/Dr. Kian Karimi MD describes the blunt cannula for injectable fillers. Finally, a way to perform fillers with truly minimal risk of bruising, far less swelling, and less pain than traditional injection techniques. All fillers including Juvederm, Restylane, Perlane, and Radiesse can be injected usin